Exact Mass: 615.0372047999999
Exact Mass Matches: 615.0372047999999
Found 10 metabolites which its exact mass value is equals to given mass value 615.0372047999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Trametinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].
Poly(ethyleneglycol) 2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl ether
C14H14F17NO4S (615.0372047999999)
N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide
n-n-propyl-n-(2,3-dihydroxypropyl)perfluorooctyl sulfonamide
C14H14F17NO4S (615.0372047999999)
GDP-4-oxo,6-deoxy-D-lyxo-heptose
C17H23N5O16P2-2 (615.0615018000001)
GDP-6-deoxy-4-keto-L-xylo-heptose
C17H23N5O16P2-2 (615.0615018000001)
GDP-6-deoxy-4-keto-L-ribo-heptose
C17H23N5O16P2-2 (615.0615018000001)
GDP-6-deoxy-4-keto-D-arabino-heptose
C17H23N5O16P2-2 (615.0615018000001)
[4-[6-Benzyl-5-[[4-oxo-3-[(4-sulfooxyphenyl)methyl]dioxetan-3-yl]amino]pyrazin-2-yl]phenyl] hydrogen sulfate
C26H21N3O11S2 (615.0617476000001)
Lamellarin alpha 20-sulfate
C29H22NNaO11S (615.0811222000001)
An organic sodium salt of lamellarin alpha 20-hydrogen sulfate. It is isolated from an unidentified ascidian (IIC-197) and exhibits inhibitory activity against HIV-1 integrase.